MORENO, C.; AIELLO, A.; DI VIRGILIO, R.; MAZZOTTA, V.; ANTINORI, A. Cost-effectiveness analysis of nirmatrelvir/ritonavir in adult patients at high risk of progressing to severe COVID-19. Global and Regional Health Technology Assessment, [S. l.], v. 11, n. 1, p. 168–176, 2025. DOI: 10.33393/grhta.2024.3403. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/3403. Acesso em: 22 jul. 2025.